Skip to content
Use caution Drug recall · FDA · Published May 20, 2015

Mylan Recalls Mycophenolic Acid Tablets Due to Dissolution Failure

Mylan Lab Inc recalls specific lots of Mycophenolic Acid Delayed-release Tablets because they failed dissolution specifications. Check your bottle's lot number.

🇺🇸 FDA recall #D-1111-2015DrugMylan ›
Take action

Contact the company

Recalling firmMylan Lab Inc1500 Corporate Dr Ste 400 · Canonsburg, PA 15317-8580
✎ GovInfoNow plain-language explainer

What happened, in plain English

Mylan Lab Inc is recalling a specific batch of Mycophenolic Acid Delayed-release Tablets, 180 mg, in 120-count bottles. The recall was issued because the tablets did not meet dissolution specifications, meaning they may not release the medication properly. This could affect how well the drug works for patients who rely on it. Read more at govinfonow.com/recall/44675-mylan-lab-inc-recalls-mycophenolic-acid-delayed-release-tablets-180.

Source Summary by GovInfoNow · govinfonow.com/recall/44675-mylan-lab-inc-recalls-mycophenolic-acid-delayed-release-tablets-180 · Updated October 12, 2026 · FDA enforcement record: FDA #D-1111-2015

Cite this page

“Mylan Recalls Mycophenolic Acid Tablets Due to Dissolution Failure.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44675-mylan-lab-inc-recalls-mycophenolic-acid-delayed-release-tablets-180. Based on FDA recall #D-1111-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1111-2015%22&limit=1).

Why it’s dangerous

The tablets failed dissolution specifications, resulting in low out-of-specification dissolution results. This means the medication might not dissolve or release as intended, potentially leading to ineffective treatment for the condition it is prescribed to treat.

Who’s affected

Patients currently taking Mycophenolic Acid Delayed-release Tablets, 180 mg, from the recalled lot are affected. Individuals who purchased these specific bottles nationwide prior to May 20, 2015, may have the product.

How to tell if you have this one

Check your bottle for NDC 0378-4201-78 and UPC 3 0378-4201-78 7. The recalled lot number is 3059043 with an expiration date of 08/16. The product contains 180 mg tablets in a 120-count bottle.

  • Brand
    Mylan
  • Product
    Mycophenolic Acid Delayed-release Tablets, 180 mg, 120-count bottle, Rx only, Mylan Pharmaceuticals, Inc., Morgantown
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Verify if your bottle matches NDC 0378-4201-78, UPC 3 0378-4201-78 7, Lot # 3059043, and Exp 08/16.

  2. Contact Your Pharmacist

    If you have the recalled product, contact your pharmacist or healthcare provider for instructions on how to proceed.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 17 months after the firm started it.

1. Firm started the recall: May 20, 201512. FDA classified it Class II: May 29, 201523. Published in FDA’s Enforcement Report: Jun 10, 201534. FDA terminated the recall: Oct 21, 2016420152016
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1111-2015 (May 20, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1111-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA